Oscar Health, Inc. (OSCR) Financial Ratios
7 years of historical data (2019–2025) · Healthcare · Medical - Healthcare Plans
EV/EBITDA
N/A
—
5yr avg: 26.23
30Y Low26.2·High26.2
P/FCF
↑
6.96
↑+137% vs avg
5yr avg: 2.94
30Y Low1.5·High3.8
P/B Ratio
↑
7.60
↑+231% vs avg
5yr avg: 2.29
30Y Low0.6·High3.8
ROE
↑
-44.4%
↓+83% vs avg
5yr avg: -262.3%
30Y Low-53%·High3%
Debt/EBITDA
N/A
—
5yr avg: 3.35
30Y Low3.4·High3.4
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
OSCR Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Oscar Health, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis. On a free-cash-flow basis, the stock trades at 7.0x P/FCF, 137% above the 5-year average of 2.9x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Market Cap | $7.4B | $3.8B | $3.6B | $2.0B | $523M | $1.4B | — | — |
| Enterprise Value | $5.0B | $1.4B | $2.3B | $457M | $-737908447 | $301M | — | — |
| P/E Ratio → | -16.80 | — | 140.44 | — | — | — | — | — |
| P/S Ratio | 0.63 | 0.32 | 0.39 | 0.35 | 0.13 | 0.73 | — | — |
| P/B Ratio | 7.60 | 3.84 | 3.52 | 2.52 | 0.59 | 1.01 | — | — |
| P/FCF | 6.96 | 3.56 | 3.76 | — | 1.49 | — | — | — |
| P/OCF | 6.73 | 3.44 | 3.65 | — | 1.37 | — | — | — |
P/E links to full P/E history page with 30-year chart
OSCR EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.12 | 0.26 | 0.08 | -0.18 | 0.16 | — | — |
| EV / EBITDA | — | — | 26.23 | — | — | — | — | — |
| EV / EBIT | — | — | 41.03 | — | — | — | — | — |
| EV / FCF | — | 1.35 | 2.47 | — | -2.10 | — | — | — |
OSCR Profitability
Margins and return-on-capital ratios measuring operating efficiency
Oscar Health, Inc. earns an operating margin of -3.4%. A negative ROE of -44.4% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 14.4% | 14.4% | 20.1% | 20.8% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | -3.4% | -3.4% | 0.6% | -4.0% | -14.8% | -29.7% | -68.8% | -46.8% |
| Net Profit Margin | -3.8% | -3.8% | 0.3% | -4.6% | -14.7% | -29.8% | -69.0% | -47.2% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| ROE | -44.4% | -44.4% | 2.8% | -31.9% | -53.1% | -1185.2% | — | — |
| ROA | -7.9% | -7.9% | 0.6% | -6.7% | -15.4% | -20.5% | -22.5% | -19.4% |
| ROIC | — | — | — | — | — | -148.3% | — | — |
| ROCE | -25.3% | -25.3% | 2.1% | -9.4% | -41.1% | -48.4% | -22.4% | — |
OSCR Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $2.8B exceeds total debt of $430M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.44 | 0.44 | 0.29 | 0.37 | 0.33 | — | — | — |
| Debt / EBITDA | — | — | 3.35 | — | — | — | — | — |
| Net Debt / Equity | — | -2.39 | -1.21 | -1.95 | -1.41 | -0.79 | — | — |
| Net Debt / EBITDA | — | — | -13.73 | — | — | — | — | — |
| Debt / FCF | — | -2.21 | -1.29 | — | -3.59 | — | -3.28 | — |
| Interest Coverage | -23.85 | -23.85 | 2.41 | -9.86 | -25.97 | -119.89 | -114.48 | — |
Net cash position: cash ($2.8B) exceeds total debt ($430M)
OSCR Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.95x is below 1.0, meaning current liabilities exceed current assets — though the company's $2.8B cash position helps mitigate short-term liquidity concerns. The current ratio has improved from 0.90x to 0.95x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.95 | 0.95 | 0.90 | — | 1.26 | 1.71 | — | — |
| Quick Ratio | 0.95 | 0.95 | 0.90 | — | 1.26 | 1.71 | — | — |
| Cash Ratio | 0.82 | 0.82 | 0.68 | — | 0.91 | 1.05 | — | — |
| Asset Turnover | — | 1.85 | 1.90 | 1.63 | 0.91 | 0.58 | 0.26 | 0.41 |
| Inventory Turnover | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — |
OSCR Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Oscar Health, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | 0.7% | — | — | — | — | — |
| FCF Yield | 14.4% | 28.1% | 26.6% | — | 67.2% | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Shares Outstanding | — | $262M | $266M | $222M | $212M | $179M | $239M | $239M |
Peer Comparison
Compare OSCR with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 OSCRYou | $7B | -16.8 | — | 7.0 | 14.4% | -3.4% | -44.4% | — | — |
 CLOV | $3B | -29.4 | — | — | 18.5% | -4.4% | -26.3% | -34.0% | — |
 ALHC | $4B | -5908.1 | 93.4 | 39.5 | 12.4% | 0.4% | -0.5% | — | 7.5 |
 ACGL | $32B | 7.8 | 6.6 | 5.3 | 37.2% | 25.0% | 19.5% | 15.4% | 0.5 |
 BHVN | $1B | -2.0 | — | — | — | — | -310.8% | -242.1% | — |
 MIRA | $40M | -0.7 | — | — | — | — | -165.9% | -461.4% | — |
 UNH | $364B | 30.3 | 17.9 | 22.6 | 18.5% | 4.2% | 11.8% | 9.2% | 3.4 |
 CVS | $125B | 70.7 | 14.0 | 16.1 | 13.8% | 2.6% | 2.3% | 5.0% | 6.2 |
 CI | $74B | 12.6 | 8.3 | 8.8 | 9.5% | 3.3% | 14.3% | 10.4% | 2.7 |
 ELV | $84B | 15.5 | 11.2 | 26.6 | 25.6% | 4.1% | 13.3% | 9.1% | 3.4 |
 CNC | $30B | -4.5 | — | 7.0 | 12.2% | -3.9% | -28.7% | -21.6% | — |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 7 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
OSCR — Frequently Asked Questions
Quick answers to the most common questions about buying OSCR stock.
What is Oscar Health, Inc.'s P/E ratio?
Oscar Health, Inc.'s current P/E ratio is -16.8x. The historical average is 140.4x.
What is Oscar Health, Inc.'s ROE?
Oscar Health, Inc.'s return on equity (ROE) is -44.4%. The historical average is -31.6%.
Is OSCR stock overvalued?
Based on historical data, Oscar Health, Inc. is trading at a P/E of -16.8x. Compare with industry peers and growth rates for a complete picture.
What are Oscar Health, Inc.'s profit margins?
Oscar Health, Inc. has 14.4% gross margin and -3.4% operating margin.